Evidence map›Paper›PMID 32986367›Full record

ArticleAsian Pacific journal of cancer prevention : APJCP2020

Association of ApaI and TaqI polymorphisms in VDR Gene with Breast Cancer.

Amir Hassan Matini, Negar Jafarian-Dehkordi, Banafshe Bahmani, Mehran Sharifi, Danial Jahantigh, Tahereh Mazoochi

Open access · goldAbstract read
In one paragraph

Article in Asian Pacific journal of cancer prevention : APJCP, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. The Link BetweenBioMed research international · 2026
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Amir Hassan MatiniDepartment of Pathology, School of Medicine, Kashan University of Medical Sciences, Kashan, Iran.
Negar Jafarian-DehkordiDepartment of Pathology, School of Medicine, Kashan University of Medical Sciences, Kashan, Iran.
Banafshe BahmaniDepartment of Pathology, School of Medicine, Kashan University of Medical Sciences, Kashan, Iran.
Mehran SharifiDepartment of Hematology and Oncology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Danial JahantighDepartment of Biology, Faculty of Science, University of Sistan and Baluchestan, Zahedan, Iran.
Tahereh MazoochiDepartment of Pathology, School of Medicine, Kashan University of Medical Sciences, Kashan, Iran.
Kashan University of Medical Sciences · IRIsfahan University of Medical Sciences · IRUniversity of Sistan and Baluchestan · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundVitamin D inhibits cell proliferation via the vitamin D receptor (VDR), which may affect breast cancer risk. This study aimed to investigate the association of ApaI and TaqI polymorphisms of the VDR gene with breast cancer risk which followed by stratified analysis. MATERIALS AND

methodsA case-control study was conducted on 150 breast cancer patients and 150 healthy controls. VDR ApaI and TaqI genotyping were performed by PCR-RFLP. Some demographic and pathologic features of patients were extracted from their archived files and then were analyzed by genotypes distributions.

resultsFor ApaI polymorphism, our data showed a significant difference between the patient and healthy groups for mutant allele carriers compared with those with AA genotype. Besides, statistical analysis showed that there was a significant association between the C allele and the increased risk of breast cancer. For TaqI polymorphism, statistical analysis revealed that there was a significant association between CC genotype and increased risk of breast cancer. Also, there was a significant association between the C allele and the increased risk of breast cancer. In a preliminary study, stratified analysis based on the size of tumor and lymph node metastasis revealed no significant association between two ApaI and TaqI variations and these parameters.

conclusionsBased on our results, the VDR ApaI and TaqI variations could be considered as genetic risk factors for breast cancer. However, further studies with a larger sample size are required to obtain more accurate outcomes, especially in stratified analysis.

Indexed as

Genetic Predisposition to DiseasePolymorphism, Single NucleotideBiomarkers, TumorBreast NeoplasmsCase-Control StudiesDeoxyribonucleases, Type II Site-SpecificFemaleFollow-Up StudiesGenotypeHumansPolymerase Chain ReactionPolymorphism, Restriction Fragment LengthPrognosisReceptors, CalcitriolBiomarkers, TumorDeoxyribonucleases, Type II Site-SpecificGGGCCC-specific type II deoxyribonucleasesReceptors, CalcitriolTCGA-specific type II deoxyribonucleasesVDR protein, humanApaIbreast cancerGenetic polymorphismTaqIVitamin D receptor

Identifiers

PMID32986367
PMCPMC7779446
OpenAlexW3091735113

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.